Many congratulations to OPKO EUROPE, a company close to OAFI, for winning the SETRADE Award

Congratulations to OPKO EUROPE, a company close to OAFI, for winning the SETRADE Award for Best Work for its interest in Sports Traumatology and Scientific Quality 2017: Efficacy and tolerance of the unique plasma complex for musculoskeletal regeneration: PROGEN. Thanks to this supplement based on a plasma complex, the combination of hyaluronic acid and chondroitin sulphate (HC-15®), collagen and vitamin C, it has been demonstrated that after surgery of the anterior cruciate ligament (ACL), Progen helps a faster recovery from the injury, accelerating the maturation of the graft, assessed blindly by MRI, and a decrease in the pain reflected in the almost total reduction of the analgesic intake 3 months after surgery.

(See news: http://www.setrade.org/actualidad/noticias_ficha.php?id=330)
OPKO, a multinational biopharmaceutical and diagnostic company established in essential sectors of healthcare, bases its activity on the discovery, development and marketing of innovative technologies.
OPKO Europe is one of OAFI’s partner companies with which we collaborate. We are currently participating jointly in a controlled clinical trial on a new treatment for osteoarthritis together with the SETRADE Scientific society.
Many thanks to OPKO for its unconditional support, which makes it possible to advance in research, pain treatment and the improvement of the quality of life of people with osteoarthritis, and congratulations on the award.